Skip to main content

Lumason FDA Approval History

Last updated by Judith Stewart, BPharm on Dec 5, 2019.

FDA Approved: Yes (First approved October 10, 2014)
Brand name: Lumason
Generic name: sulfur hexafluoride lipid microsphere
Dosage form: Injectable Suspension
Company: Bracco Diagnostics Inc.
Treatment for: Diagnosis and Investigation

Lumason (sulfur hexafluoride lipid microsphere) is a contrast agent used for ultrasound imaging.

Development timeline for Lumason

Oct 10, 2014Approval FDA Approves Lumason Ultrasound Imaging Agent

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.